Farther Finance Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Farther Finance Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-82	Closed	-$2.72K	–	2450
2022 Q4	$2.72K	Buy	+82	New	+$2.64K	﹤0.01%	1342

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farther Finance Advisors's VIVO Position: Q1 2023 in Review

Farther Finance Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 82 shares — an estimated $2.72K sold.

Farther Finance Advisors first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $2.72K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Farther Finance Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Farther Finance Advisors sold 82 Meridian Bioscience Inc shares in Q1 2023, an estimated $2.72K.
Farther Finance Advisors first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Farther Finance Advisors's Meridian Bioscience Inc position peaked at $2.72K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Farther Finance Advisors's 13F filing for Q1 2023, filed 12 Sep 2023.